Published on 29.8.2016 in Vol 5, No 3 (2016): Jul-Sept

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Cari Stek^{1, 2, 3}

; Charlotte Schutz^{1, 3}

; Lisette Blumenthal^{1, 3}

; Friedrich Thienemann^{1, 3}

; Jozefien Buyze²

; Christiana Nöstlinger⁴

; Raffaella Ravinetto²

; Edwin Wouters⁵

; Robert Colebunders²

; Gary Maartens³

; Robert J Wilkinson^{1, 3, 6, 7}

; Lutgarde Lynen²

; Graeme Meintjes^{1, 3}

Article Authors Cited by (9) Tweetations (2) Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Daily | Monthly | Annually